These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
690 related articles for article (PubMed ID: 33218024)
1. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model. Choi Y; Shin B; Kang K; Park S; Beck BR Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study. Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y Eur J Pharmacol; 2021 Apr; 896():173922. PubMed ID: 33539819 [TBL] [Abstract][Full Text] [Related]
3. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S J Genet; 2021; 100(1):. PubMed ID: 33707363 [TBL] [Abstract][Full Text] [Related]
4. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
5. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. Muralidar S; Gopal G; Visaga Ambi S J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation. Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407 [TBL] [Abstract][Full Text] [Related]
7. Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo. Jiang WP; Deng JS; Yu CC; Lin JG; Huang GJ Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892254 [TBL] [Abstract][Full Text] [Related]
8. Prevention of SARS-CoV-2 cell entry: insight from Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728 [TBL] [Abstract][Full Text] [Related]
9. Repositioning of histamine H Ge S; Wang X; Hou Y; Lv Y; Wang C; He H Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607 [TBL] [Abstract][Full Text] [Related]
10. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Gkogkou E; Barnasas G; Vougas K; Trougakos IP Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 Interactions. Lin H; Cherukupalli S; Feng D; Gao S; Kang D; Zhan P; Liu X Curr Med Chem; 2022; 29(4):682-699. PubMed ID: 33881969 [TBL] [Abstract][Full Text] [Related]
13. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19. Ahmad I; Pawara R; Surana S; Patel H Top Curr Chem (Cham); 2021 Oct; 379(6):40. PubMed ID: 34623536 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
15. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections. Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922 [TBL] [Abstract][Full Text] [Related]
16. Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester. Kumar V; Sari AN; Gupta D; Ishida Y; Terao K; Kaul SC; Vrati S; Sundar D; Wadhwa R Curr Top Med Chem; 2024; 24(9):830-842. PubMed ID: 38279743 [TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters. Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210 [TBL] [Abstract][Full Text] [Related]